The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players !

[Automatic translation follows] The priorities of the Ministry of National Education, Higher Education and Research are: - improve student success and promote equal opportunities; - to coordinate the training offer in French higher education; - to set priority areas for progress in knowledge and technologies; - as well as the public research and innovation strategy. In this context, the so-called "ESR" law of July 22, 2013 also advocates transformation and openness to all forms of teaching and research, to the socio-economic environment, internationally. Among the key measures put in place: - The definition of a national higher education strategy (StraNES) …

[Automatic translation follows] Prevention / Care / Research / Teaching, serving patients with #cancer. Gustave Roussy, the leading cancer center in Europe, 4th best cancer hospital in the world, constitutes a global center of expertise against cancer, serving patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Grand Paris). A private establishment of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and teaching

Sectors: Health

[Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospital establishments. Founded in 1909 on a model designed by Marie Curie and still at the forefront, “from fundamental research to innovative care”, the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Cares The Institut Curie Hospital Complex is a reference center for breast cancers, eye tumors and pediatric cancers in particular. The research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians …

Sectors: Health

Une capitale French Tech à l'écoute des start-up deeptech de Paris-Saclay « La French Tech » : c’est le mouvement français des startups. Un écosystème unique qui réunit des startups (donc), mais aussi des investisseurs, des décideurs et des community builders. La French Tech Paris-Saclay Capitale labélisée en IdF au côté de la capitale French Tech Grand Paris.

Sectors: French Tech

[Automatic translation follows] Innovation with confidence Created in 2014 and resulting from the “Investments for the Future” Program, SATT Paris-Saclay is the Technology Transfer Acceleration Company of the Paris-Saclay Cluster. A common player in both groups – Université Paris-Saclay and Institut Polytechnique de Paris – SATT has an investment capacity of 66 million euros over 10 years to finance and support the valorization of research work from the territory and the technology transfer to markets. Innovation, Technology Transfer, and Start-ups

Tags: SATT Network Sectors: Research Startup accelerator & VC

[Automatic translation follows] The Pitié-Salpêtrière hospital is a hospital of the Assistance publique - Hôpitaux de Paris (AP-HP) located 47-83, boulevard de l'Hôpital in the 13th arrondissement of Paris.

Sectors: Health

[Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies, from start-up to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region adapted to each stage of the life of companies. As a partner bank for entrepreneurs, Bpifrance supports them over the long term to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee

Sectors: Bank

Filiale du CNRS & de BPI France. 30 ans d'expertise au service de l'innovation et du transfert de technologies. CNRS Innovation, established in 1992, is a French public limited company, now a subsidiary of the CNRS at 90% and 10% Bpifrance Financement. Its mission is to transfer innovative technologies, mainly originating from the CNRS, to the industry. Its action extends from the receipt of projects to the granting of exploitation rights through consulting in Intellectual Property strategies, participation in the filing of patent applications, seeking of industrial partners, negotiating and drafting of exploitation agreements, and management of patent portfolios. CNRS …

Sectors: Research

80 years of building new worlds through knowledge The French National Centre for Scientific Research is among the world's leading research institutions. Its scientists explore the living world, matter, the Universe, and the functioning of human societies in order to meet the major challenges of today and tomorrow. Internationally recognised for the excellence of its scientific research, the CNRS is a reference in the world of research and development, as well as for the general public. Recherche scientifique, Biologie, Chimie, Ecologie et environnement, Ingénierie et systèmes, Mathématiques, Physique, Sciences de l'information, Homme et société, Nucléaire et particules, Terre et Univers, …

Sectors: Research

Campus Biotech is a Swiss center of excellence in biotechnology and life sciences research. Campus Biotech is a new centre of excellence in biotechnology and life science research. It focuses on pure science and its translation into practical outcomes that have an impact on society and the world. Campus Biotech is expected to generate a vast range of opportunities, bringing impetus and investment to this vital economic and scientific sector.

Sectors: Biotechnology Startup accelerator & VC

Through cutting-edge science and medicine, Biogen discovers, develops and delivers innovative therapies worldwide for people living with serious neurological and neurodegenerative diseases. Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront of neurology research for conditions including Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis. Biogen also manufactures and commercializes biosimilars of advanced biologics. With approximately 7000 people worldwide, we are truly a global organization, headquartered in Cambridge, Massachusetts, …

Sectors: Biotechnology

Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and …

Sectors: French Cluster Public business cluster

Bringing you news and information from the European Commission The Commission represents and upholds the interests of the EU as a whole, and is independent of national governments. The European Commission prepares legislation for adoption by the Council (representing the member countries) and the Parliament (representing the citizens). It administers the budget and the policy programmes (agriculture, fisheries, research etc.) in cooperation with authorities in the member countries. Visit http://www.europa.eu/ if you want to learn more about the EU, or call the free service number 00 800 6789 10 11 from anywhere in the EU, they speak all 24 official …

Sectors: European Union

Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par …

Sectors: Health

The French national research institute for digital science and technology World-leading research and technological innovation are an integral part of its DNA. Inria's 3,500 researchers and engineers put their passion for digital technology to work in nearly 200 project teams, most of which are joint teams with our academic partners, including major research universities and the CNRS. They explore new fields, often in collaboration with different disciplines and industrial partners, with the aim of meeting ambitious challenges. As a technology institute, Inria supports the development of numerous software products, sometimes making a global impact via the opensource model. Because technology …

Sectors: Research

We advance science so that we all have more time with the people we love. Are you ready to join us? Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is …

Sectors: Biotechnology Pharmaceutical

What science can do We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business

Sectors: Pharmaceutical

Transforming Tomorrow Together UK Research and Innovation (UKRI) is the public sector organisation that invests £8 billion annually to support the entire research and innovation system. We strive for a society powered and empowered by research and innovation, with economic, social, environmental and cultural benefits for all. We invest in people, places, ideas, innovation and impacts, empowering researchers, innovators and entrepreneurs to turn the many challenges we all face into opportunities, driving up prosperity and wellbeing across the UK and globally. The impacts of our work are felt right across society. We enrich lives by increasing our understanding of ourselves …

Sectors: Public business cluster

There's always a way to make life better. Over the past decade we have transformed into a focused leader in health technology. At Philips, our purpose is to improve people’s health and well-being through meaningful innovation. We aim to improve 2.5 billion lives per year by 2030, including 400 million in underserved communities. We see healthcare as a connected whole. Helping people to live healthily and prevent disease. Giving clinicians the tools they need to make a precision diagnosis and deliver personalized treatment. Aiding the patient's recovery at home in the community. All supported by a seamless flow of data. …

Sectors: Electricals

At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. ​ All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. ​ Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals

Sectors: Pharmaceutical